Home Procedures Transjugular Liver Biopsy & HVPG

Transjugular Liver Biopsy & HVPG Measurements

Safe transjugular liver biopsy and Hepatic Venous Pressure Gradient (HVPG) measurement for patients with severe coagulopathy, ascites or high bleeding risk performed by Dr. Gurucharan S Shetty at Sparsh Hospitals Bangalore.

Hepatobiliary Interventional Radiology

What is Transjugular Liver Biopsy & HVPG?

Transjugular Liver Biopsy (TJLB) is a minimally invasive procedure in which liver tissue is sampled via the jugular vein rather than through the skin over the liver. A catheter is guided from the jugular vein through the hepatic vein inside the liver, and a biopsy needle collects tissue from within the venous system. Any bleeding flows harmlessly back into the vein rather than into the abdomen, making it the safest method for high-risk patients. Simultaneously, the Hepatic Venous Pressure Gradient (HVPG) the gold standard for quantifying portal hypertension can be measured during the same session, giving a complete hepatic assessment in one procedure.

Who is This Procedure For?

Transjugular liver biopsy (TJLB) is specifically recommended for patients in whom conventional percutaneous liver biopsy carries an unacceptably high bleeding risk or is technically not feasible. This includes individuals with severe coagulopathy (INR >1.5 or platelet count <50,000/µL) due to advanced liver disease, haematological disorders, or ongoing anticoagulation therapy. It is also preferred in patients with tense ascites, where large abdominal fluid collections make a percutaneous approach unsafe or difficult. TJLB is indicated in cases of vascular liver lesions such as haemangiomas or highly vascular tumours, where there is a higher risk of haemorrhage. Additionally, it is useful when hepatic venous pressure gradient (HVPG) measurement is required during the same procedure. The technique is often employed following a failed or complicated percutaneous biopsy and is also valuable in liver transplant evaluation, both pre- and post-transplant, particularly when coagulation parameters are abnormal.

How is the Procedure Performed?

  • Jugular Vein Access

    Under ultrasound guidance, the right internal jugular vein is punctured and a short introducer sheath is placed.

  • Hepatic Vein Catheterisation

    A catheter is guided under fluoroscopy through the superior vena cava, right atrium, inferior vena cava, and into the right hepatic vein.

  • HVPG Measurement

    Pressure readings are taken in free and wedged positions. Balloon occlusion venography confirms accurate wedge position.

  • Liver Biopsy Sampling

    A transjugular biopsy needle passes through the catheter into liver parenchyma. 3–5 passes obtain adequate core tissue for histopathology.

  • Post-Procedure Monitoring

    Vital signs and ultrasound confirm no haemorrhage. Most patients are discharged the same day or next morning.

img

Benefits of This Procedure

Safe in High-Risk Patients

Eliminates peritoneal haemorrhage risk safe even in severe coagulopathy where percutaneous biopsy is contraindicated.

HVPG in Same Session

Complete portal pressure quantification and liver biopsy in a single anaesthetic episode avoiding a second procedure.

Adequate Tissue Sample

3–5 core biopsies provide sufficient material for histology, IHC, fibrosis scoring (Metavir/Ishak), and special stains.

Rapid Recovery

Patients are typically discharged the same evening or next morning after brief observation.

Frequently Asked Questions

Yes this is the primary advantage of the transjugular approach. Because biopsy is taken from within the hepatic venous system, any bleeding flows back into the vein and does not accumulate in the abdomen. It is specifically designed for patients with severe coagulopathy (INR >1.5, low platelets) where conventional percutaneous biopsy carries unacceptable haemorrhage risk. Dr. Shetty's team will provide detailed pre-procedure medication instructions.
The procedure is performed under conscious sedation you will be relaxed and comfortable but awake. Local anaesthetic is applied at the neck before jugular puncture. Most patients report minimal discomfort. General anaesthesia is not required.
Most patients are observed for 4–6 hours post-procedure and discharged the same evening or next morning. A post-procedure ultrasound is routinely performed. You should arrange for someone to drive you home and rest for 24–48 hours.
HVPG ≥10 mmHg confirms clinically significant portal hypertension guiding variceal screening and beta-blocker therapy. HVPG >12 mmHg indicates high variceal bleeding risk. A repeat HVPG after starting treatment confirms whether you are a haemodynamic responder, which significantly reduces complication risk.
Routine histopathology results are available within 3–5 working days. Special stains, immunohistochemistry, or fibrosis scoring may take 5–7 days. Dr. Shetty's team will contact you to discuss results and plan next steps.
Book Consultation with Dr. Shetty

Need a Safe Liver Biopsy or Portal Pressure Assessment?

Consult Dr. Gurucharan S Shetty at Sparsh Hospitals, Bengaluru for expert evaluation and a personalised minimally invasive hepatic assessment.

Book Appointment